Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...
Most medicines used worldwide are off-patent products – generic or biosimilar versions of branded medicines offering the same quality, safety, and efficacy at a lower price. They are the ‘silent ...
The highly purified omega-3 fatty acid formulation was approved for this indication by the Medicines and Healthcare products Regulatory ... Society for Medical Oncology (ESMO) 2024 meeting was ...